Currently out of the existing stock ratings of Narumi Nakagiri, 4 are a HOLD (40%), 6 are a BUY (60%).

Narumi Nakagiri

Work Performance Price Targets & Ratings Chart

Analyst Narumi Nakagiri, currently employed at DAIWA, carries an average stock price target met ratio of 80% that have a potential upside of 9.06% achieved within 111 days.

Narumi Nakagiri’s has documented 21 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on JNJ, Johnson & Johnson at 20-Oct-2025.

Wall Street Analyst Narumi Nakagiri

Analyst best performing recommendations are on JNJ (JOHNSON & JOHNSON).
The best stock recommendation documented was for JNJ (JOHNSON & JOHNSON) at 7/23/2024. The price target of $150 was fulfilled within 2 days with a profit of $5.22 (3.61%) receiving and performance score of 18.03.

Average potential price target upside

AMGN Amgen MRK Merck mpany PFE Pfizer ABBV AbbVie BMY Bristol-Myers Squibb Company JNJ Johnson & Johnson ILMN Illumina

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 10-Jan-2025

$375

$27.06 (7.78%)

$325

1 months 20 days ago
(19-Feb-2026)

13/14 (92.86%)

$-0.5 (-0.13%)

284

Buy Since 02-Jan-2025

$432

$84.06 (24.16%)

$381

1 months 21 days ago
(18-Feb-2026)

9/10 (90%)

$52.27 (13.77%)

150

Buy Since 06-Feb-2023

$400

$52.06 (14.96%)

$270

2 months 2 days ago
(06-Feb-2026)

1/2 (50%)

$18.32 (4.80%)

330

Hold Since 20-May-2025

$347

$-0.94 (-0.27%)

$288

2 months 2 days ago
(06-Feb-2026)

1/2 (50%)

$-34.68 (-9.09%)

23

Hold Since 10-Feb-2022

$309

$-38.94 (-11.19%)

$304

2 months 4 days ago
(04-Feb-2026)

19/21 (90.48%)

$-54.68 (-15.04%)

714

Show more analysts

Please expand the browser size to see the chart

Which stock is Narumi Nakagiri is most bullish on?

Potential upside of $-40.04 has been obtained for JNJ (JOHNSON & JOHNSON)

What Year was the first public recommendation made by Narumi Nakagiri?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?